HAEE and derivatives in neuronal function research — RU2822603C1
Sergey A. Kozin, Artur T. Kopylov, Evgeniya M. Karpova, Ruslan Y. Yakovlev · 2024 · RU2822603C1 · patent family RU2822603C1
Published 2024-07-09.
Reported patent results
Reported findings
Approximately 100 pg/mL over 30 days in the cited cell culture example.
In a human induced pluripotent stem cell-derived neuron and astrocyte culture, the authors measured the reported secreted factor by HPLC–MS in conditioned medium.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Reported secreted factor in culture medium | Approximately 100 pg/mL over 30 days in the cited cell culture example. |
The culture result measures a reported secreted factor. It does not establish recovery in patients or identify the exact HAEEPGP sequence as a tested preparation.
Source for these results ↗ · Reviewed 2026-11-12
Patent claims and provenance
Use. Claims HAEE and specified derivative preparations for neuronal function recovery.
The culture result measures a reported secreted factor. It does not establish recovery in patients or identify the exact HAEEPGP sequence as a tested preparation.
- Publication
- RU2822603C1 ↗ · 2024-07-09
- Earliest priority / filing
- 2023-03-03 / 2023-03-03
- Original applicant / assignee
- Lifemission LLC
- Indexed status
- Not shown; official status unverified · checked 2026-11-12
- Patent family
- Grouping identifier unavailable · family publications are related filings, not independent studies.
Original title, inventors and related publications
HAEE and derivatives in neuronal function research
Inventors: Sergey A. Kozin; Artur T. Kopylov; Evgeniya M. Karpova; Ruslan Y. Yakovlev.
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The culture result measures a reported secreted factor. It does not establish recovery in patients or identify the exact HAEEPGP sequence as a tested preparation.
- The culture result measures a reported secreted factor. It does not establish recovery in patients or identify the exact HAEEPGP sequence as a tested preparation.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; each record lists the review date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Available format: Original patent text and indexed metadata
Material reviewed: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related publications may cover the same research program or participants.
Source access
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Source reviewed 2026-11-12.
Source type: Patent publication
Citation and original source
Original source: Sergey A. Kozin, Artur T. Kopylov, Evgeniya M. Karpova, Ruslan Y. Yakovlev. HAEE and derivatives in neuronal function research — RU2822603C1 RU2822603C1 · patent family RU2822603C1 2024.
Molekul research summary: https://molekul.io/research/patent-ru2822603c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry